S6K1-mediated disassembly of mitochondrial URI/PP1gamma complexes activates a negative feedback program that counters

Nabil Djouder1, Stefan Christian Metzler, Alexander Schmidt

  • 1Institute of Cell Biology, Swiss Federal Institute of Technology (ETH) Zurich, 8093 Zurich, Switzerland.

Molecular Cell
|October 16, 2007
PubMed

Insights

The study reveals that URI and protein phosphatase 1 gamma (PP1gamma) form mitochondrial complexes that regulate cell survival signaling. This pathway ensures apoptosis thresholds align with nutrient availability, opposing sustained survival signals.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • S6 kinase 1 (S6K1) is a key regulator of cell growth and survival, integrating nutrient and growth factor signals.
  • S6K1 phosphorylates and inactivates the proapoptotic molecule BAD, promoting cell survival.
  • Mitochondria play a crucial role in apoptosis and are a site for S6K1 activity.

Purpose of the Study:

  • To investigate the role of the prefoldin chaperone URI in S6K1-mediated cell survival.
  • To elucidate the mechanism by which S6K1 regulates mitochondrial pathways involved in apoptosis.
  • To identify novel components of the S6K1 signaling network at the mitochondria.

Main Methods:

  • Cell culture and treatment with growth factors or rapamycin.
  • Co-immunoprecipitation to detect protein complex formation.
  • Western blotting to assess protein phosphorylation and levels.
  • Enzyme activity assays for PP1gamma.

Main Results:

  • URI forms stable complexes with protein phosphatase (PP)1gamma at mitochondria in growth factor-deprived cells, inhibiting PP1gamma activity.
  • Growth factor stimulation causes S6K1-mediated phosphorylation of URI at serine 371, leading to the disassembly of URI/PP1gamma complexes.
  • Disassembly of these complexes activates a PP1gamma-dependent negative feedback loop, reducing S6K1 activity and BAD phosphorylation, thus altering the apoptosis threshold.

Conclusions:

  • URI and PP1gamma are integral components of an S6K1-regulated mitochondrial pathway.
  • This pathway opposes sustained S6K1 survival signaling and fine-tunes the mitochondrial apoptosis threshold based on nutrient and growth factor availability.
  • The findings reveal a novel feedback mechanism controlling cell survival and apoptosis.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...